Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 08/27/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-7809-24
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24)
- Initial Posting
- 08/27/2025
- Revised Date